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Using stable isotope dilution, we determined the bioavailability of soilborne lead (Pb) in human
adult volunteers. Soil from a residential yard at a mining-impacted federal Superfund site that had
negligible amounts of other priority pollutants was dried and screened through a 25- pm mesh
sieve. The <250-pm fraction, which likely represents that ingested via hand-to-mouth activity,
was then sterilized by exposure to radiation. Ten replicate samples yielded a mean (SD) soil Pb
concentration of 2924±36 ppm, and a mean 206Pb/207Pb ratio of 1.1083±0.0002, indicating
remarkable soil homogeneity. Six adults with 206Pb/207Pb ratios of > 1.190 were admitted to the
clinical research center and fasted overnight prior to dosing with 250 pg Pb/70 kg bw (i.e., 85.5
mg soilf70 kg) in a gelatin capsule. Blood for Pb and 206Pb/207Pb ratios was obtained at 14 time
points through 30 hr. Results of the isotopic analyses from these subjects indicate that on
average 26.2% ±8.1 of the administered dose was absorbed. Six additional subjects were
subsequently studied but ingested soil immediately after a standardized breakfast. Bioavailability
in this group was only 2.52% ± 1.7. Collectively, this study provides the first experimental
estimates of soil Pb absorption in humans, and should allow for more precise estimates of health
risks due to Pb-contaminated soil. Environ Health Perspect 106(Suppl 6):1589-1594 (1998).
http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-6/1589-1594maddaloni/abstract.html
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The regulation ofenvironmental contami-
nants such as lead (Pb) should reflect the
potential impact on human health and the
environment. With respect to soilborne
Pb contamination, the bioavailability of
Pb in that medium will to a great extent
determine its capacity to adversely affect
human health. The U.S. Environmental
Protection Agency (U.S. EPA) employs
the integrated exposure uptake biokinetic
(IEUBK) model for lead to assess envi-
ronmental Pb hazards in children (1) and
has developed an interim simplified
biokinetic model for use in adults (2)
while the U.S. EPA explores expansion of
the IEUBK model to accommodate all age
groups. In addition, there are a number of
biokinetic models available (3-5) that are
intended for use in adults. The output of
these models is affected by a host of
exposure and kinetic factors, with the
bioavailability of Pb in soil among the
more prominent (6). Unfortunately, this
parameter is among the most poorly
understood and likely contains a high
degree ofuncertainty.
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In the past, investigators have employed
animal models to study the bioavailability of
Pb in soil (7,8). These studies, however,
have primarily focused on predicting
bioavailability in children rather than in
adults. For example, using immature swine
as a surrogate for young children, Casteel
et al. (7) conducted a bioavailability study
of soils from the Smuggler Mountain
Superfund site in Aspen, Colorado. Two
soils were tested at three different doses and
were administered in daily feed material for
15 days. The average absolute bioavailability
in all six test groups was 28%. Employing a
rat model, Freeman et al. (8) studied the
bioavailability of Pb-contaminated mining
waste from the Butte, Montana, Superfund
site. Soils with high (3908 ppm) and low
(810 ppm) Pb concentrations were mixed
with varying amounts of feed material to
mimic the soil ingestion pattern ofchildren
with pica. Relative bioavailability was meas-
ured against a Pb acetate standard that was
added as a solution to the feed material. The
dietary feeding studywas conducted over 39
days. Analysis of blood Pb (PbB) data
yielded a relative bioavailability of20%.
Until now, however, there have been no
controlled studies assessing the bioavailabil-
ity ofsoilborne Pb in humans. Past human
dietary studies employing solubilized Pb in
an aqueous vehicle (9-11) may provide
some insight regarding the extent of Pb
absorption from soil. However, the Pb/soil
matrix is believed to influence absorption
through factors such as Pb speciation, parti-
cle size distribution, and organic/mineral
content of the soil (12). Steele et al. (12)
and Mushak (13) have reviewed the influ-
ence ofsoil characteristics on Pb absorption
using epidemiologic studies, in vitro tests,
and animal bioassays. For example, particle
size affects both the dissolution ofPb in in
vitro systems (14) and the bioavailability of
Pb in animal models (15). The dissolution
rate ofPb is proportional to the Pb-bearing
surface area. As particle size decreases, there
is a corresponding increase in surface area
per unitweight ofmaterial.
Medlin (14) developed a method for
estimating the bioavailability ofsoilborne
Pb through use ofan in vitro test for meas-
uring the dissolution of Pb from various
Pb-bearing minerals. Among six minerals
studied (galena [PbS], slag, cerussite,
pyromorphite, Pb oxide, and anglesite
[PbSO4]), an average 5-fold increase in
solubility occurred when the <38-p
particle size was compared to the 150- to
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250-p size range. Barltrop and Meek (15)
observed a nonlinear inverse relationship
between particle size and PbB when rats
were administered metallic Pb particles
ranging in size from 5 to 200 p in their
diet over a 48-hr period.
The chemical species ofPb influences its
solubility. Ruby et al. (16) have demon-
strated a direct relationship between Pb sol-
ubility, as measured by a physiologically
based extraction test and bioavailability in
animal models. Additional evidence of the
impact ofspeciation on bioavailability can
be illustrated by the relationship between
soil Pb concentration and PbB in communi-
ties impacted by either smelting or mining
waste. Pb associated with mining waste con-
sists primarily of PbS altered to PbSO4 in
the surficial waste piles, whereas the preva-
lent forms ofPb at smelter sites are the more
soluble oxides (lead monoxide [PbO] and
lead dioxide [PbO9]) (17). Steele et al. (12)
reviewed epidemiologic studies that related
PbB to soil Pb concentration (i.e., slope
studies) and derived an average slope of 1.7
pg/dl PbB per 1000 ppm Pb in soil from
mining-impacted soilborne Pb, as opposed
to 4.6 pg/dl PbB per 1000 ppm Pb in soil
from smelting-impacted waste.
In addition, Pb uptake in the gastro-
intestinal tract is affected by the presence of
such nutrients as calcium, iron, phosphate,
vitamin D, fats, and fiber, as they occur
with meals or snacks. In adults, it is well
known that Pb uptake is markedly lower
when ingested with meals than under
(.
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fasting conditions (9-11). Human data, in
the aggregate, indicate that calcium, iron,
and other cations interact stronglv as com-
petitors of Pb uptake so that Pb absorptioni
generally increases as dietary levels of these
nutrients decrease (13, 18).
This study is the first of its kind to
directly measure the absorption of soil-
borne Pb in humans. It included extensive
characterization of soil matrix factors that
impact bioavailability. The results of this
study are intended to improve biokinetic
modeling of soilborne Pb hazards at sites
(i.e., indtistrial) in which adults rather than
children are the primaiy targets ofexposure.
Stable Isotope Dilution:
Principles and Applications
Lead has four stable isotopes, 04Pb, 2`6Pb,
207Pb, and 208iPb, ofwhich the last three are
continually being produced by radioactive
decay. Thus, Pb in industrial use can vary
greatly in its stable isotope ratios accordinig
to the geologic age of the Pb deposit. For
example, the ratio of 2tiGPb/ir)7Ib in the
Broken Hill, Australia, Pb deposit is 1.03;
in the younger U.S. deposits of the
Mississippi Valley it is as high as 1 .42 (19).
An individual's bodv buriden of I'b
possesses an isotopic fingerprint reflecting
the sources of Pb exposure in that person's
environment. We previously reported fre-
quency distributions of blood 20icPb/2(07IPb
ratios for huiman populations in three
different geographic locations; American
subjects had higher 206Pb/2017Pb ratios than
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Figure 1. Frequency distribution of 206Ph/207Pb isotope ratios in normal volunteers recruited for this study compared
to the 2ttPh/207Pb isotope ratio of the Bunker Hill soil sample.
subjects from Australia or Scotland (20).
The sensitivity of the stable isotope dilu-
tion technique as an analytical tool to
study bioavailability is driven by the differ-
ence between the blood 2()6Pb/20i7Pb
isotopic ratio and that ofthe exogenous Pb
source (i.e., in this case, soil) (Figure 1).
Soil samples from U.S. EPA Superfund
sites arotind the United States were
obtained to find a soil that contained a
2`J6Pb/2ii7Pb isotopic ratio strikingly differ-
ent from the blood 20i6Pb/207Pb isotopic
ratios previously established for American
subjects in New York. Soil 2t)6Pb/2(T7Pb
ratios ranged from a low of 1.057 at
Bunker Hill, Idaho, to a high of 1.253 at
Triumph, Idaho (Table 1). Sample calcula-
tions were performed to test analytical sen-
sitivity by matching soils with low
'()Pb/2iiTPb ratios to American subjects,
anid soils with high 20)6Pb/207Pb ratios to
Scottish and Australian subjects. Thus, we
estimated that ifAmerican subjects with
blood 20)6Pb/207Pb ratios > 1.190 were to
ingest soil (250 pg Pb/70 kg bw) from
Bunker Hill, we would be able to precisely
estimate bioavailability even if it were
extraordinarily low.
Preparation and
Characterization ofthe
Bunker Hill Soil Sample
A 2.5-kg surface soil sample was obtained
from a residential yard at the Bunker Hill
Superfund site. Historical information
indicated that mine tailings had been uti-
lized extensively as fill material in this area
(21). After mixing, a subsample was
screened for priority pollutants by the U.S.
EPA Region II's Edison, New Jersey, labo-
ratory (22). Lead and arsenic were the only
contaminants found above trace or non-
detectable levels. At 34 ppm, the calculated
dose of arsenic to be administered in this
study (approximately 3 pg) would be well
below the 340 pg typically found in 8 oz of
lobster meat (23). In contrast, the concen-
tration of Pb in the gross soil sample was
2240 ppm.
Soil drying was accomplished by air
drying in a filtered incubator at room tem-
perature for 8 days. The soil contained
Table 1. Lead isotope ratios from various sites.
Location Superfund site 206Pb/207Pb
Bunker Hill, Idaho Bunker Hill 1.057
Butte, Montana Silver Bow Creek 1.148
Leadville, Colorado California Gulch 1.170
Buffalo, New York Bern Metal 1.205
Triumph, Idaho Triumph Mine 1.253
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2.4% residual moisture. The soil was then
manually sieved through a 250-pm mesh;
theyield was 24% byweight. Relative to the
bulk soil sample, the concentration ofPb in
the sieved fraction increased from 2240 to
2924 ppm. The resultant sieved soil fraction
was then sterilized by y irradiation (Medical
Sterilization Inc., Syosset, NY).
Ten replicate soil samples were analyzed
for Pb concentration and 206Pb/207Pb ratio.
Soil Pb was extracted by leaching in hot
concentrated nitric acid for 8 hr. The
mean ±SD Pb concentration was 2924±36
ppm and the mean ±SD 206Pb/207Pb ratio
was 1.1083 ±0.0002, indicating remarkable
soil homogeneity (Table 2).
Duplicate samples of the sterilized
material were characterized for Pb specia-
tion and particle size distribution. A 10-g
aliquot ofthe soil was divided in two and
particle mineralogy was identified using an
electron microprobe, according to the
method ofDavis et al. (24).
Particle size distribution was determined
using an electrozone sensor in an Elzone 280
PC System (Particle Data Laboratories,
Elmhurst, IL). The particle size distribution
indicated that 79.5% ofthe particles were
<20 pm (Figure 2). The Pb speciation pro-
file was dissimilar between the split samples.
Because the variability in the speciation pro-
file was inconsistent with the homogeneity
demonstrated via Pb concentration, isotopic
ratio, and particle size distribution, a repeat
Pb speciation profile was performed. The
repeat analysis resulted in a more homoge-
nous profile, suggesting a possible "nugget
effect" in one of the original duplicate
samples. A nuggeteffect occurs when aparti-
de with a heavily concentrated predominant
Pb form skews the species profile. In any
case, mean values from the four speciation
profiles are presented in Figure 3.
Clinical and Laboratory
Methods
The soil ingestion study was approved by
the Columbia Presbyterian Medical Center
(CPMC) Institutional Review Board and
written informed consent was obtained
from all subjects. The subjects, healthy
adults between 21 to 40 years ofage, were
screened prior to study to assure that they
had normal urinalyses, blood chemistries,
blood counts, and physical exams, and that
their PbB was <5 pg/dl and blood
206Pb/207Pb ratio was > 1.190. All were
within 10% oftheir ideal weight for height
based on the Metropolitan Life tables.
Subjects were admitted to the Columbia
Presbyterian Irving Center for Clinical
Table 2. Soil homogeneity.
Sample no. Weight, g Lead, ppm 206Pb/207Pb
1 0.1091 2858 1.1084
2 0.0968 2952 1.1082
3 0.0944 2928 1.1083
4 0.1037 2965 1.1083
5 0.0963 2931 1.1080
6 0.1003 2914 1.1084
7 0.0919 2912 1.1087
8 0.0988 2942 1.1081
9 0.0921 2967 1.1083
10 0.0988 2876 1.1084
Mean SD 0.0982±0.0053 2924±36 1.1083±0.0002
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Figure 2. Frequency distribution of the soil grain size in the Bunker Hill residential soil sample.
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Research (ICCR) on day 1 at 5:00 P.M.
and remained in the ICCR for the dura-
tion of the study (until 1:00 P.M. on day
3). Following admission, they received a
regular hospital dinner and then fasted
overnight except for water. At 6:00, 6:30,
and 7:00 A.M. on day 2, baseline PbB and
206Pb/207Pb samples were taken. A baseline
urine sample was also collected from
admission until 7:00 A.M. on day 2.
Immediately following the 7:00 A.M.
blood drawing on day 2, subjects ingested
soil that contained 250 pg Pb/70 kg bw.
This dose was chosen as the maximum dose
that could be safely administered with the
following safety considerations in mind. An
individual weighing 70 kg has approximately
5 liters ofblood. A 70-kg subject with a PbB
of 5 pg/dl (the maximum eligible PbB for
this study) would therefore have approxi-
mately 250 pg Pb in the blood compart-
ment. Even if Pb absorption was complete
(i.e., bioavailability= 100%) and instanta-
neous, this dose of Pb would increase the
PbB from 5 to 10 pg/dl (the currently
accepted upper limit ofnormal PbB).
The soil was ingested in a No. 6
gelatin capsule, with 240 cc of water.
Blood and urine were collected over the
next 30 hr and analyzed for Pb and
206Pb/207Pb ratio. Blood samples were
collected in Becton Dickinson trace ele-
ment vacutainer tubes (Becton Dickinson,
East Rutherford, NJ) with sodium
heparin. Urine samples were collected in
acid-washed plastic bottles. All tubes and
bottles were purchased in one lot prior to
the start of the study and were randomly
sampled to check for contamination.
The concentration of Pb in soil was
2924 ppm and in the fasted group (group
1) the mean subject weight was 59.7 kg,
resulting in an average administered soil
dose of 72.9 mg (Table 3). In the non-
fasted group (group 2), the mean subject
weight was 67.9 kg, resulting in an average
soil dose of82.9 mg.
On day 2, the subjects in group 1
received no breakfast, a standardized liquid
lunch at noon, and a standardized dinner
at 5:00 P.M. They received a standardized
breakfast and lunch on day 3. The protocol
was identical for group 2, except that this
group received a standardized high-fat
breakfast at 6:45 A.M. on day 2 immedi-
ately prior to the soil Pb administration.
Breakfast consisted of25 g ofwheat cereal,
130 g ofwhole milk, 1 large hard-boiled
egg (approximately 48 g), 50 g of firm
whole wheat bread, 6 g of butter, 5 g of
jam/preservatives, and 6 g ofwhite sugar.
The total calories consumed with this meal
was 430, with 15% coming from protein,
51% from carbohydrates, and 33% from
fat. The breakfast contained 255 mg ofcal-
cium and 418 mg ofphosphorus. All meals
were prepared in duplicate and analyzed
for Pb content, which was unremarkable at
<0.5 ppm Pb dryweight.
The ratio of206Pb/207Pb and total Pb
content were simultaneously measured in
the blood. An appropriate quantity of205Pb
was added as an internal standard to each
blood sample, which was then decomposed
by boiling in concentrated HNO3. The
solution was evaporated to dryness and the
residue charred at 250°C. Pb was then
extracted by anion exchange chromato-
graphy and isotopically analyzed on a
Finnigan MAT 261 multicollector mass
spectrometer (Finnigan Instruments,
Bremen, Germany) (25). Pb blanks for the
method were consistently <25 pg Pb. The
accuracy ofthe spike calibration was verified
by analysis ofstandard SRM 955a, Lead in
Blood (National Institute ofStandards and
Technology). Accuracy of the isotopic
analyses was monitored by analyzing SRM
981, Common Pb. All other blood and
urine analyses were performed by the
CPMC clinical laboratories.
Results
The demographic characteristics of the
study subjects are presented in Table 3.
Prior to ingestion ofthe soil, the mean PbB
in the fasted group was 1.59 pg/dl and the
mean 206Pb/207Pb ratio was 1.195. Thirty
hours after soil administration, the PbB
rose to a mean value of2.6 pg/dl (p=0.02)
and the 206Pb/207Pb ratio fell to a mean
value of 1.166 (p=0.0001). In contrast, the
PbB in the fed group rose by only 0.3
pg/dl, whereas the 206Pb/207Pb ratio fell by
only 0.004 These changes were essentially
complete by 24 hr. Typical absorption
profiles from subjects in the fed and fasted
groups are presented in Figure 4A and B,
respectively. The absorption profile pre-
sented in Figure 4, for example, demon-
strates the remarkable sensitivity of the
stable isotope dilution technique. This sub-
ject had both the lowest baseline PbB (0.7
pg/dl) and the smallest increase in PbB
among fasted subjects (0.5 pg/dl) following
ingestion ofthe soil, yet soil and nonsoil Pb
sources could readily be distinguished.
On average, at 24 hr, we could account
for 14.4% ±4.5 of the administered Pb
dose in the blood compartment of the
fasted subjects. Bioavailability is tradition-
ally estimated by comparing the kinetics of
an oral dose to those of an intravenous
Table 3. Subject demographics and study findings.
PbB, pg/dl 206Pb/207Pb
Subject Age, years Race Gender Weight, kg Pb dose, pg Soil dose, pg Start 24 hr Start 24 hr Bioavailability, %
Group 1, fasted 1 26 White F 56.5 202 69.0 1.94 3.34 1.193 1.165 35.6
2 27 Asian M 57.8 206 70.5 1.52 2.16 1.193 1.169 22.6
3 30 Hispanic F 53.2 190 65.0 2.04 2.81 1.191 1.173 19.0
4 24 Asian F 59.0 211 72.1 0.71 1.28 1.199 1.160 18.0
5 26 Hispanic F 65.5 234 80.0 1.57 2.82 1.194 1.158 36.6
6 33 Hispanic M 66.0 236 80.6 1.77 2.75 1.200 1.175 25.4
Mean 28 59.7 213 72.9 1.59* 2.53* 1.195** 1.167** 26.2
Group 2, fed 7 28 Hispanic M 79.2 283 96.7 4.60 5.10 1.196 1.195 1.8
8 30 White M 78.5 280 95.9 2.12 2.37 1.201 1.195 5.2
9 26 White F 64.0 229 78.2 1.02 1.06 1.201 1.194 2.3
10 25 White F 60.2 215 73.6 2.55 2.59 1.186a 1.186 0.2a
11 27 White F 63.5 227 77.6 1.22 1.31 1.190 1.185 2.3
12 29 White F 61.7 220 75.4 1.92 2.12 1.195 1.191 3.3
Mean 28 67.9 242 82.9 2.24 2.42 1.195 1.191 2.52
Abbreviations: F, female; M, male. aThis subject's 206Pb/207Pb ratio dropped from 1.194 at the initial screening to 1.186 just prior to administration of the soil capsule. The
cause of this change is unknown but likely had an effect on this value. When this value is deleted, the mean bioavailability in group 2 is 2.98%. *p=0.0268; **p=0.0001.
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Figure 4. Change in blood lead concentration after ingestion of a soil containing 250 pg Pb/70 kg bw in a fasted (A) and a nonfasted (B) subject. , total blood lead concen-
tration. By the technique of stable isotope dilution, we were able to differentiate the relative contribution of soil lead (e) and endogenous lead (o) to total lead.
dose. Previous studies ofintravenous 203Pb
(26-28) indicate that at 24 hr, 55% of an
administered dose is still in the blood com-
partment. In this manner, we estimated the
mean fraction ofPb absorbed from the soil
sample to be 26.2%± 8.1, with a range of
18.0 to 36.6%. In the six fed subjects,
1.4% ±0.9 ofthe administered Pb dose was
present in the blood compartment at 24
hr. Consequently, the estimated mean frac-
tion of Pb absorbed in this group is
2.52% ± 1.7 (range 0.2-5.2%).
Discussion
The hazard posed by Pb-contaminated soils
has and continues to be ofgreat interest to
organizations, such as the U.S. EPA, with
public health and regulatory mandates. The
intent ofthis research project is to provide
experimental data that will better enable the
U.S. EPA and similar agencies to assess and
regulate the widespread soilborne Pb conta-
mination in nonresidential areas throughout
the United States.
Biokinetic models that assess the impact
of Pb-contaminated soil have had to
estimate the bioavailability ofsoilborne Pb
by extrapolating from dietary exposure
studies in humans and/or soil-feeding
studies in animals. The strength of the
current study is that it directly examines
human Pb bioavailability in a contaminated
soil sample obtained from a hazardous
waste site. In addition, the soil sample
contains a Pb concentration (2924 ppm)
that is commonly encountered at sites
undergoing remedial investigation, and the
amount ofsoil administered (72.9 and 82.9
mg) approximates the range estimated
[20-80 mg (29)] for normal daily soil
ingestion by adults.
Although the study design strived to
mimic an actual exposure scenario, it is
unlikely that the daily soil ingested by an
adult occurs as a bolus. Estimates of inci-
dental daily soil ingestion in adults, though
poorly defined, are associated with
mouthing activities. The repetitive nature of
these activities (e.g., smoking, eating, etc.)
leads to soil ingestion throughout the day.
Ideally, experimental soil administration
should occur in a pattern that simulates real-
life exposure; however, practical considera-
tions make this an extraordinarily difficult
task. Therefore, as a concession to practical-
ity, we administered the soil as a bolus and
recognized the possible limitations of this
dosing regimen. However, the compara-
tively small tracer dose of Pb administered,
even as a bolus, seems unlikely to result in
saturable kinetics (8,30).
The lack of speciation homogeneity
between duplicate soil samples raised a
concern regarding the results of the soil
bioavailability study. Possible differences in
the Pb speciation profile across the adminis-
tered soil samples introduces the possibility
that the variance in absorption fraction
within each of the test groups could have
included variance due to Pb speciation
rather than simply variance due to
interindividual variability. Also, a lack of
homogeneity in soil Pb speciation reduces
the confidence in projecting the results of
the soil bioavailability study as being
representative ofa particular profile ofphy-
sicochemical soil/Pb characteristics.
Nevertheless, this type of microhetero-
geneity in speciation likely occurs at many
sites around the world.
Various investigators (9-11) have
demonstrated absorption in the range of
30 to 70% when solubilized Pb was
administered to fasted subjects. These
same investigators (9-11) demonstrated
significantly reduced absorption (range
3.5-9%) when solubilized Pb was admin-
istered with a meal. The results ofour soil
bioavailability study are consistent with
that trend, in that absorption was approx-
imately an order of magnitude different
(2.5% vs 26.1%) between the fasted and
fed states, respectively.
In conclusion, we believe that this
experimental model provides important
new information that supplements that
obtained from observational epidemiologic
studies of soil Pb/PbB relationships. The
generalizability of these findings to other
soils or to remediated sites is not known
but can be determined experimentally
using this in vivo model.
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